| Financial Year |
March 31 2023 |
| Monetary Funds |
89,984,360.58 |
| Held-for-trading Financial Assets |
17,181,652.25 |
| Notes Receivable |
52,914,053.90 |
| Accounts Receivable |
2,756,996,516.12 |
| Advances to Suppliers |
40,397,658.38 |
| Other Receivables |
82,361,244.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,014,254.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
135,915,069.67 |
| Total Current Assets |
3,321,224,343.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
889,911,947.62 |
| Investment Properties |
225,608,595.92 |
| Fixed Assetes |
3,667,745,761.47 |
| Under-construction Projects |
13,903,960.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,977,569.38 |
| R&D expenses |
-- |
| Goodwill |
201,464,586.98 |
| Long-Term Deferred and Prepaid Expenses |
9,237,918.24 |
| Deferred Income Tax Assets |
127,515,515.39 |
| Other Non-Current Assets |
12,642,840.43 |
| Sub-Total of Non-Current Assets |
11,505,763,649.20 |
| Total Assets |
14,826,987,992.53 |
| Short-Term Loans |
927,607,591.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,499,167,960.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,828,373.72 |
| Taxes Payable |
70,875,456.42 |
| Interest Payable |
-- |
| Dividend Payable |
4,800,000.00 |
| Other payables |
738,318,393.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,555,722,978.42 |
| Other Current Liabilities |
31,319,530.31 |
| Sub-Total of Current Liabilities |
4,920,653,178.45 |
| Long-term Loans |
324,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
494,352,670.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
68,453,368.33 |
| Other Non-Current Liabilities |
220,000,000.00 |
| Sub-Total of Non-Current Liabilities |
5,079,582,850.16 |
| Total Liabilities |
10,000,236,028.61 |
| Paid-In Capital(Or Share Stock) |
1,388,442,826.00 |
| Capital Surplus |
1,270,935,307.20 |
| Surplus Reserve |
93,572,499.24 |
| LESS:Treasury Stock |
51,000,000.00 |
| Undistributed Profits |
2,027,855,167.23 |
| Minority Stockholder's Interest |
96,946,164.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,729,805,799.67 |
| Owner's Equity（Stockholder's Equity） |
4,826,751,963.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,826,987,992.53 |
